News

Jul 9, 2008 Luitpold Pharmaceuticals/American Regent and Fresenius Medical Care sign agreements for exclusive sublicense of Venofer® in U.S.
Mar 12, 2008 Luitpold Pharmaceuticals INJECTAFER™ (ferric carboxymaltose injection) receives non-approvable letter from FDA
Mar 10, 2008 
Feb 5, 2008 FDA Advisory Panel Supports Favorable Risk-Benefit Profile for Injectafer™ Under Certain Indications
Dec 18, 2007 Osteohealth Company to Aquire Dental Therapeutics Business
Dec 20, 2005 Osteohealth Company Announces FDA Approval of GEM 21S® Growth-factor Enhanced Matrix for the Treatment of Periodontally-related Bone Defects
Oct 17, 2005 Venofer® receives FDA Approval for the treatment of Iron Deficiency Anemia in Peritoneal Dialysis Patients
Jun 17, 2005 Venofer® receives FDA approval for the Treatment of Iron Deficiency Anemia in CKD
Mar 29, 2005 American Regent launches Calcitriol Injection
Nov 19, 2004 BioMimetic Pharmaceuticals Receives Approvable Recommendation from FDA Advisory Panel for GEM 21S™
Oct 29, 2003 Luitpold Pharmaceuticals, Inc. Acquires Drug Targeting Technology And Targaceutical® Drug Candidates
© 2008, Luitpold Pharmaceuticals, Inc. Terms of Use | Privacy Policy